Compliance: Waste Not, Want Not Where Drugs Are Concerned, Says OIG
Target: Multi-use drugs.
Medical practices were given a slap on the wrist by the Office of the Inspector General (OIG) for wasting precious units of multi-vial drugs. You can now expect to have to repay for units which you did not use but billed incorrectly because the vial had to be thrown away.
The OIG’s report, which the agency issued on Feb. 5, revealed that when the OIG audited claims for full vials of Herceptin — a breast cancer drug — it found that 80 percent were billed incorrectly, totaling more than $1 million in overpayments to medical...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.
Current newsletters added each month
Fully searchable archives - over 4200 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
Access to this feature is available in the following products: